(Q40849506)

24 September 2017

p53 protein expression in non-Hodgkin's lymphoma. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1. (English)

1 reference

24 September 2017

Tzardi M

1

1 reference

24 September 2017

Kouvidou C

2

1 reference

24 September 2017

Panayiotides I

3

1 reference

24 September 2017

Stefanaki K

4

1 reference

24 September 2017

Rontogianni D

5

1 reference

24 September 2017

Zois E

6

1 reference

24 September 2017

Koutsoubi K

7

1 reference

24 September 2017

Eliopoulos G

8

1 reference

24 September 2017

Delides G

9

1 reference

24 September 2017

Kanavaros P

10

1 reference

24 September 2017

1 October 1996

1 reference

Clinical Molecular Pathology

24 September 2017

1 reference

24 September 2017

49

1 reference

24 September 2017

5

1 reference

24 September 2017

M278-82

1 reference

MDM-2 protein expression in nasopharyngeal carcinomas. Comparative study with p53 protein expression

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

The p53-mdm-2 autoregulatory feedback loop

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

p21 is a universal inhibitor of cyclin kinases

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

WAF1, a potential mediator of p53 tumor suppression

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Mutations in the p53 gene occur in diverse human tumour types

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

The p53 tumour suppressor gene

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408073

Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease

19 August 2018

1 reference

12 December 2020

The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin

1 reference

12 December 2020

Induction of p21 (WAF-1/CIP1) during differentiation

1 reference

12 December 2020

Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells

1 reference

12 December 2020

P53 protein expression in lymphomas and reactive lymphoid tissue

1 reference

12 December 2020

The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations

1 reference

12 December 2020

Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma

1 reference

12 December 2020

The human MDM-2 oncogene is overexpressed in leukemias

1 reference

12 December 2020

Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas

1 reference

12 December 2020

MDM2 gene amplification in metastatic osteosarcoma

1 reference

12 December 2020

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

12 December 2020

MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression

1 reference

12 December 2020

Identifiers

DOI

10.1136/MP.49.5.M278

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

16696089

1 reference